An observational study in Genital Diseases, Female and Pelvic Organ Prolapse, sponsored by Medway NHS Foundation Trust. Completed at 1 site in United Kingdom. Open to female participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2018-05-29.
Sponsored by Medway NHS Foundation Trust · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Prolapse of the vaginal wall and uterus are common conditions affecting up to 50% of parous women. The socioeconomic, psychological and physical impacts of prolapse are considerable. 11% of women will undergo a surgical repair by the age of 80 years. The commonest compartment affected is the anterior vaginal wall. Unfortunately there is a significant rate of recurrent prolapse or a failure of the primary procedure. This has lead to the introduction of new techniques and the use of different materials to augment the repair. Mesh augmented repairs aim to reduce the rate of recurrent prolapse. However, the use of synthetic mesh is associated with complications which are not found in non mesh repairs. 10% of women will have a mesh complication of which 70% will require a further surgical procedure to manage the complication. There are extra costs associated with purchasing the mesh, with longer operating times to insert the mesh and managing complications caused by the mesh. Balancing the extra risks of mesh surgery against the benefits is probably one of the most contentious issues in urogynaecology at the present time.
Regulatory authorities in the USA (FDA) and UK (MHRA) have become increasingly interested in the use of mesh to support the vaginal wall in prolapse surgery due to risks and complications being reported. To date there is little evidence regarding the long term safety and efficacy of anterior mesh repairs. This study aims to rectify this deficiency for Perigee.
This will be a consecutive cohort study of patients identified from a surgical database of Perigees performed in a single centre. All patients will have had the procedure performed between 2007 and 2011. This will be a single centre study. The principle investigator has both electronic and hand written records of all Perigee repairs performed since the introduction of this technique in 2007. The patients will be identified from both the paper and electronic databases and cross referenced.
After obtained appropriate ethical approval, patients identified as having a perigee mesh inserted will be asked to attend Medway Hospital for a full clinical evaluation. They will be sent a letter with an appointment to come to the hospital. They will be asked to complete the Pelvic floor distress inventory questionnaire to assess their symptoms. They will have a pelvic examination to determine if they have any mesh erosion and will undergo a POP-Q score. This visit will take 1 hour.
161 studies on the registry are indexed under Genital Diseases, Female; 31 are open to participants now.
This study's enrollment of 48 is below the median of 200 across 37 observational studies indexed under Genital Diseases, Female.
Browse Genital Diseases, Female studies →Medway NHS Foundation Trust is the lead sponsor of 13 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Consecutive patients having previously undergone a mesh repair
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
retrospective review of case series
The Number of Participants With a Current Mesh Erosion or Treated for a Mesh Erosion Since Inserted
clinic visit. 5 patients were interviewed by phone and were not examined - hence this figure is out of 43 not 48.
Time frame: 1 hour
Number of Participants With no Physical Evidence of Recurrent Prolapse as Determined by Physical Examination
The presence of less than stage 2 prolapse (eg stage 1) anterior wall prolapse determined as anatomical success. A stage one prolapse is higher than 1cm above the vaginal entrance. A stage 2 prolapse means that the leading edge of the prolapse is between 1cm above the entrance to the vagina up to 1cm below the entrance to the vagina.
Time frame: 1 hour
Number of Participants Complaining of a Bulge. Recurrent Prolapse
Efficacy determined by the question in the pelvic floor prolapse distress inventory "usually have a bulge or something falling out that you can see or feel in your vaginal area". Determined at clinic visit by questioning
Time frame: 1 hour
Number of Participants Requiring Treatment for Recurrent Prolapse - Prolapse in the Same Part of the Vagina
clinic visit; number of participants who underwent reoperation of recurrent prolapse in the same compartment
Time frame: 1 hour
Number of Participants Who Underwent Reoperation for Prolapse in a Different Compartment
This is where the mesh has held up and there is no prolapse where it was inserted. This measure refers to when a different part of the vagina has prolapsed.
Time frame: 1 hour
Number of Participants Who Developed New Stress Incontinence
The mesh has caused the prolapse to be successfully repaired but the patient has developed stress incontinence as a separate issue. clinic visit
Time frame: 1 hour
Number of Participants Who Rated Their Improvement as Better or Very Much Better
The patient global impression of Improvement scale (PGI-I) is a global improvement scale filled out by the patient. It is graded as very much better, much better, a little better. no change, a little worse, much worse or very much worse.clinic visit
Time frame: 1 hour
Number of Participants Who Needed Surgical Mesh Removal for Erosion
A mesh erosion is when the body rejects the mesh and it is visible in the vagina rather than being buried under the vaginal epithelium. clinic visit
Time frame: 1 hour
Number of Participants Who Needed Reoperations for Pain
patients may develop pain after the original operation which needs a second surgical procedure to try and help. clinic visit
Time frame: 1 hour
Number of Participants Who Experienced Intraoperative Complications
This records any problems that were encountered at the original insertion of the mesh. clinic visit
Time frame: 1 hour
| Milestone | Mesh Group |
|---|---|
| Started | 48 |
| Completed | 48 |
| Not completed | 0 |
clinic visit. 5 patients were interviewed by phone and were not examined - hence this figure is out of 43 not 48.
| Participants | Mesh Group |
|---|---|
| The Number of Participants With a Current Mesh Erosion or Treated for a Mesh Erosion Since Inserted | 5 |
The presence of less than stage 2 prolapse (eg stage 1) anterior wall prolapse determined as anatomical success. A stage one prolapse is higher than 1cm above the vaginal entrance. A stage 2 prolapse means that the leading edge of the prolapse is between 1cm above the entrance to the vagina up to 1cm below the entrance to the vagina.
| Participants | Mesh Group |
|---|---|
| Number of Participants With no Physical Evidence of Recurrent Prolapse as Determined by Physical Examination | 26 |
Efficacy determined by the question in the pelvic floor prolapse distress inventory "usually have a bulge or something falling out that you can see or feel in your vaginal area". Determined at clinic visit by questioning
| Participants | Mesh Group |
|---|---|
| Number of Participants Complaining of a Bulge. Recurrent Prolapse | 14 |
clinic visit; number of participants who underwent reoperation of recurrent prolapse in the same compartment
| Participants | Mesh Group |
|---|---|
| Number of Participants Requiring Treatment for Recurrent Prolapse - Prolapse in the Same Part of the Vagina | 1 |
This is where the mesh has held up and there is no prolapse where it was inserted. This measure refers to when a different part of the vagina has prolapsed.
| Participants | Mesh Group |
|---|---|
| Number of Participants Who Underwent Reoperation for Prolapse in a Different Compartment | 8 |
The mesh has caused the prolapse to be successfully repaired but the patient has developed stress incontinence as a separate issue. clinic visit
| Participants | Mesh Group |
|---|---|
| Number of Participants Who Developed New Stress Incontinence | 5 |
The patient global impression of Improvement scale (PGI-I) is a global improvement scale filled out by the patient. It is graded as very much better, much better, a little better. no change, a little worse, much worse or very much worse.clinic visit
| Participants | Mesh Group |
|---|---|
| Number of Participants Who Rated Their Improvement as Better or Very Much Better | 33 |
A mesh erosion is when the body rejects the mesh and it is visible in the vagina rather than being buried under the vaginal epithelium. clinic visit
| Participants | Mesh Group |
|---|---|
| Number of Participants Who Needed Surgical Mesh Removal for Erosion | 2 |
patients may develop pain after the original operation which needs a second surgical procedure to try and help. clinic visit
| Participants | Mesh Group |
|---|---|
| Number of Participants Who Needed Reoperations for Pain | 3 |
This records any problems that were encountered at the original insertion of the mesh. clinic visit
| Participants | Mesh Group |
|---|---|
| Number of Participants Who Experienced Intraoperative Complications | 0 |
Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Mesh Group | 0/48 (0%) | 0/48 (0%) | 0/48 (0%) |
| Age, Continuous(years) | Mesh Group |
|---|---|
| Mean | 66 (47 to 83) |
| Sex: Female, Male(Participants) | Mesh Group |
|---|---|
| Female | 48 |
| Male | 0 |
| BMI(wt kg/ht m squared) | Mesh Group |
|---|---|
| Mean | 27.4 (19 to 44) |
| Parity(vaginal deliveries past 28 weeks) | Mesh Group |
|---|---|
| Median | 2 (1 to 4) |
| time to follow up (months)(number of months) | Mesh Group |
|---|---|
| Mean | 82 (48 to 106) |
The record gives a start of Aug 2015, a primary completion of Mar 2016 and a completion of Mar 2016. It does not say whether these dates are actual or estimated.
Results were first posted in May 2018, 2 years 2 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medway NHS Foundation Trust